New statewide plan aims to eliminate cervical cancer in Texas by 2032
Texas Lone Star Cervical Cancer Elimination Plan unveiled at the CPRIT 2026 Innovations Conference with the support of a statewide coalition
Texas ranks eighth in nation for incidence rate and sixth in nation for mortality rate from cervical cancer
Plan is anchored by three goals: increasing HPV vaccination, improving cervical cancer screening and ensuring appropriate diagnostic follow-up and treatment
On behalf of a statewide coalition...
UT MD Anderson honors visionary leadership of Dr. Peter Pisters following retirement announcement; shares transition plans
The University of Texas MD Anderson Cancer Center today is recognizing the exceptional leadership of Peter WT Pisters, M.D., president, following...
Allison Institute announces appointment of four new members
The James P. Allison Institute™ at The University of Texas MD Anderson Cancer Center today announced the appointment of...
MD Anderson and SOPHiA GENETICS announce strategic collaboration to accelerate AI-driven precision oncology
The University of Texas MD Anderson Cancer Center and SOPHiA GENETICS today announced a strategic collaboration that unites SOPHiA GENETICS’ AI-powered analytics with MD Anderson’s clinical and scientific expertise to accelerate data-driven cancer care through new tools that can accurately analyze, interpret and translate diagnostic results into clinical practice.
As part of the collaboration, MD Anderson and SOPHiA GENETICS are...
Leading cancer research centers reinforce importance of safe and effective HPV vaccination to prevent cancer
62 NCI-designated cancer centers, leading national organizations and the University of Puerto Rico Comprehensive Cancer Center jointly endorse...
MD Anderson and Phoenix SENOLYTIX announce strategic cross-licensing agreement to enhance inducible switch technologies for cell and gene therapies
Agreement focuses on rimiducid, an agent used to activate certain safety switch technologies in cell therapies
Phoenix receives a supply of...
MD Anderson and TOPPAN Holdings announce strategic alliance to co-develop organoid technology for evaluating cancer treatments
3D cell culture technology may allow researchers to rapidly test a variety of treatments directly on patient biopsies
Teams will evaluate technology...
UT MD Anderson and Texas Children’s Hospital announce $150 million gift from Kinder Foundation to launch Kinder Children’s Cancer Center
The University of Texas MD Anderson Cancer Center and Texas Children’s Hospital today announced a $150 million gift from Kinder Foundation...
MD Anderson and UT Austin launch joint initiative to advance breakthroughs in cancer research
The University of Texas MD Anderson Cancer Center and The University of Texas at Austin have launched a joint initiative, the Collaborative...
UT MD Anderson and Texas Children’s Hospital Announce Joint Venture to End Childhood Cancer
The University of Texas MD Anderson Cancer Center and Texas Children’s Hospital have announced a transformational collaboration dedicated...